Evidence map›Paper›PMID 30079210›Full record

ArticleChemical science2018

Inhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligase.

Eilidh K Leitch, Nagarajan Elumalai, Maria Fridén-Saxin, Göran Dahl, Paul Wan, Paul Clarkson, Eric Valeur, Garry Pairaudeau, Helen Boyd, Ali Tavassoli

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 5 countries.

Eilidh K LeitchChemistry , University of Southampton , Southampton , SO17 1RE , UK . Email: a.tavassoli@soton.ac.uk.
Nagarajan ElumalaiChemistry , University of Southampton , Southampton , SO17 1RE , UK . Email: a.tavassoli@soton.ac.uk.
Maria Fridén-SaxinMedicinal Chemistry , Cardiovascular and Metabolic Diseases , IMED Biotech Unit , AstraZeneca , Pepparedsleden 1 , Mölndal , 43150 , Sweden.
Göran DahlStructure and Biophysics , Discovery Sciences , IMED Biotech Unit , AstraZeneca , Pepparedsleden 1 , Mölndal , 43150 , Sweden.
Paul WanStructure and Biophysics , Discovery Sciences , IMED Biotech Unit , AstraZeneca , Pepparedsleden 1 , Mölndal , 43150 , Sweden.
Paul ClarksonAstraZeneca , Cambridge Science Park, 310 Milton Rd , Cambridge , CB4 0FZ , UK.
Eric ValeurMedicinal Chemistry , Cardiovascular and Metabolic Diseases , IMED Biotech Unit , AstraZeneca , Pepparedsleden 1 , Mölndal , 43150 , Sweden.
Garry PairaudeauAstraZeneca , Cambridge Science Park, 310 Milton Rd , Cambridge , CB4 0FZ , UK.
Helen BoydDrug Safety and Metabolism , IMED Biotech Unit , AstraZeneca , Pepparedsleden 1 , Mölndal , 43150 , Sweden.
Ali TavassoliChemistry , University of Southampton , Southampton , SO17 1RE , UK . Email: a.tavassoli@soton.ac.uk.ORCID 0000-0002-7420-5063
Laerdal (Norway) · NOUniversity of Southampton · GBAstraZeneca (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular uptake of circulating cholesterol occurs

Identifiers

PMID30079210
PMCPMC6050537
OpenAlexW2811141255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.